Myosin light chain kinase signaling in endothelial barrier dysfunction

Medicinal Research Reviews

Volumn 33, Issue 5, 2013, Pages 911-933

  Rigor, Robert R ^a   Shen, Qiang ^a   Pivetti, Christopher D ^a   Wu, Mack H ^b   Yuan, Sarah Y ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Edema; Endothelial barrier dysfunction; Microvascular permeability; Myosin light chain kinase (MLCK); Protein kinases

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CYCLIC GMP; HISTAMINE; MYOSIN LIGHT CHAIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; SPHINGOSINE 1 PHOSPHATE; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ACTIN FILAMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; BURN; CELL JUNCTION; DRUG TARGETING; EDEMA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; INJURY; LEUKOCYTE; MEDIATOR; MOLECULE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; SEPSIS;

EDEMA; ENDOTHELIAL BARRIER DYSFUNCTION; MICROVASCULAR PERMEABILITY; MYOSIN LIGHT CHAIN KINASE (MLCK); PROTEIN KINASES;

ANIMALS; ENDOTHELIUM; HUMANS; MOLECULAR TARGETED THERAPY; MYOSIN-LIGHT-CHAIN KINASE; PERMEABILITY; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 84881221947     PISSN: 01986325     EISSN: 10981128     Source Type: Journal    
DOI: 10.1002/med.21270     Document Type: Article

References (157)

1. Yuan SY, Rigor RR. Regulation of endothelial barrier function. In: Granger DN, Granger JP, editors. Colloquium series on integrated systems physiology: From molecule to function to disease. San Rafael (CA): Morgan & Claypool Life Sciences; 2011. pp 1-143.
2. Adamson RH, Sarai RK, Altangerel A, Thirkill TL, Clark JF, Curry FR. Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. Cardiovasc Res 2010;88(2):344-351.
3. Shen Q, Rigor RR, Pivetti CD, Wu MH, Yuan SY. Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res 2010;87(2):272-280.
4. Yuan SY. Signal transduction pathways in enhanced microvascular permeability. Microcirculation 2000;7(6 Pt 1):395-403.
5. Yuan SY. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 2002;39(4-5):213-223.
6. Takashima S. Phosphorylation of myosin regulatory light chain by myosin light chain kinase, and muscle contraction. Circ J 2009;73(2):208-213.
7. Verin AD, Gilbert-McClain LI, Patterson CE, Garcia JG. Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium. Am J Respir Cell Mol Biol 1998;19(5):767-776.
8. Lazar V, Garcia JG. A single human myosin light chain kinase gene (MLCK; MYLK). Genomics 1999;57(2):256-267.
9. Curry FR, Adamson RH. Vascular permeability modulation at the cell, microvessel, or whole organ level: Towards closing gaps in our knowledge. Cardiovasc Res 2010;87(2):218-229.
10. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006;86(1):279-367.
11. Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 2010;72:463-493.
12. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann NY Acad Sci 2008;1123:134-145.
13. Coisne C, Engelhardt B. Tight junctions in brain barriers during central nervous system inflammation. Antioxid Redox Signal 2011;15(5):1285-1303.
14. Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: Function and dysfunction. Semin Immunopathol 2009;31(4):497-511.
15. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57(2):173-185.
16. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res 2009;77(1):53-63.
17. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001;91(4):1487-1500.
18. Shen Q, Wu MH, Yuan SY. Endothelial contractile cytoskeleton and microvascular permeability. Cell Health and Cytoskeleton 2009;1:43-50.
19. Pardridge WM. Blood-brain barrier biology and methodology. J Neurovirol 1999;5(6):556-569.
20. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 2001;24(12):719-725.
21. Wu MH. Endothelial focal adhesions and barrier function. J Physiol 2005;569(Pt 2):359-366.
22. Yuan SY, Shen Q, Rigor RR, Wu MH. Neutrophil transmigration, focal adhesion kinase and endothelial barrier function. Microvasc Res 2012; 83(1): 82-8.
23. Schnittler HJ, Wilke A, Gress T, Suttorp N, Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J Physiol 1990;431:379-401.
24. Cai S, Pestic-Dragovich L, O'Donnell ME, Wang N, Ingber D, Elson E, De Lanerolle P. Regulation of cytoskeletal mechanics and cell growth by myosin light chain phosphorylation. Am J Physiol 1998;275(5 Pt 1):C1349-C1356.
25. Chrzanowska-Wodnicka M, Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 1996;133(6):1403-1415.
26. Verin AD, Patterson CE, Day MA, Garcia JG. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol 1995;269(1 Pt 1):L99-L108.
27. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 1998;273(34):21867-21874.
28. Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne DJ, Sasaki Y, Matsumura F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 2000;150(4):797-806.
29. Watterson DM, Schavocky JP, Guo L, Weiss C, Chlenski A, Shirinsky VP, Van Eldik LJ, Haiech J. Analysis of the kinase-related protein gene found at human chromosome 3q21 in a multi-gene cluster: Organization, expression, alternative splicing, and polymorphic marker. J Cell Biochem 1999;75(3):481-491.
30. Herring BP, El-Mounayri O, Gallagher PJ, Yin F, Zhou J. Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues. Am J Physiol Cell Physiol 2006;291(5):C817-C827.
31. Potier MC, Chelot E, Pekarsky Y, Gardiner K, Rossier J, Turnell WG. The human myosin light chain kinase (MLCK) from hippocampus: Cloning, sequencing, expression, and localization to 3qcen-q21. Genomics 1995;29(3):562-570.
32. Hong F, Haldeman BD, Jackson D, Carter M, Baker JE, Cremo CR. Biochemistry of smooth muscle myosin light chain kinase. Arch Biochem Biophys 2011;510(2):135-146.
33. Chan JY, Takeda M, Briggs LE, Graham ML, Lu JT, Horikoshi N, Weinberg EO, Aoki H, Sato N, Chien KR, Kasahara H. Identification of cardiac-specific myosin light chain kinase. Circ Res 2008;102(5):571-580.
34. Garcia JG, Lazar V, Gilbert-McClain LI, Gallagher PJ, Verin AD. Myosin light chain kinase in endothelium: Molecular cloning and regulation. Am J Respir Cell Mol Biol 1997;16(5):489-494.
35. Gallagher PJ, Herring BP. The carboxyl terminus of the smooth muscle myosin light chain kinase is expressed as an independent protein, telokin. J Biol Chem 1991;266(35):23945-23952.
36. Blue EK, Goeckeler ZM, Jin Y, Hou L, Dixon SA, Herring BP, Wysolmerski RB, Gallagher PJ. 220- and 130-kDa MLCKs have distinct tissue distributions and intracellular localization patterns. Am J Physiol Cell Physiol 2002;282(3):C451-C460.
37. Birukov KG, Csortos C, Marzilli L, Dudek S, Ma SF, Bresnick AR, Verin AD, Cotter RJ, Garcia JG. Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). J Biol Chem 2001;276(11):8567-8573.
38. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 2001;276(7):4527-4530.
39. Ito M, Guerriero V, Jr., Hartshorne DJ. Structure-function relationships in smooth muscle myosin light chain kinase. Adv Exp Med Biol 1991;304:3-10.
40. Garcia JG, Davis HW, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: Role of myosin light chain phosphorylation. J Cell Physiol 1995;163(3):510-522.
41. Goeckeler ZM, Wysolmerski RB. Myosin light chain kinase-regulated endothelial cell contraction: The relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol 1995;130(3):613-627.
42. Garcia JG, Siflinger-Birnboim A, Bizios R, Del Vecchio PJ, Fenton JW, 2nd, Malik AB. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol 1986;128(1):96-104.
43. Yuan Y, Huang Q, Wu HM. Myosin light chain phosphorylation: Modulation of basal and agonist-stimulated venular permeability. Am J Physiol 1997;272(3 Pt 2):H1437-H1443.
44. Tinsley JH, De Lanerolle P, Wilson E, Ma W, Yuan SY. Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability. Am J Physiol Cell Physiol 2000;279(4):C1285-1289.
45. Kuhlmann CR, Tamaki R, Gamerdinger M, Lessmann V, Behl C, Kempski OS, Luhmann HJ. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 2007;102(2):501-507.
46. Tinsley JH, Teasdale NR, Yuan SY. Myosin light chain phosphorylation and pulmonary endothelial cell hyperpermeability in burns. Am J Physiol Lung Cell Mol Physiol 2004;286(4):L841-L847.
47. Tinsley JH, Hunter FA, Childs EW. PKC and MLCK-dependent, cytokine-induced rat coronary endothelial dysfunction. J Surg Res 2009;152(1):76-83.
48. Adamson RH, Zeng M, Adamson GN, Lenz JF, Curry FE. PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. Am J Physiol Heart Circ Physiol 2003;285(1):H406-H417.
49. Cohen-Kashi Malina K, Cooper I, Teichberg VI. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. Brain Res 2009;1284:12-21.
50. Roux F, Couraud PO. Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions. Cell Mol Neurobiol 2005;25(1):41-58.
51. Reed RK, Rubin K. Transcapillary exchange: Role and importance of the interstitial fluid pressure and the extracellular matrix. Cardiovasc Res 2010;87(2):211-217.
52. Norwood N, Moore TM, Dean DA, Bhattacharjee R, Li M, Stevens T. Store-operated calcium entry and increased endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol 2000;279(5):L815-L824.
53. Hicks K, O'Neil RG, Dubinsky WS, Brown RC. TRPC-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress. Am J Physiol Cell Physiol 2010;298(6):C1583-C1593.
54. Haorah J, Heilman D, Knipe B, Chrastil J, Leibhart J, Ghorpade A, Miller DW, Persidsky Y. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Alcohol Clin Exp Res 2005;29(6):999-1009.
55. Haorah J, Knipe B, Gorantla S, Zheng J, Persidsky Y. Alcohol-induced blood-brain barrier dysfunction is mediated via inositol 1, 4, 5-triphosphate receptor (IP3R)-gated intracellular calcium release. J Neurochem 2007;100(2):324-336.
56. Ramirez SH, Potula R, Fan S, Eidem T, Papugani A, Reichenbach N, Dykstra H, Weksler BB, Romero IA, Couraud PO, Persidsky Y. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J Cereb Blood Flow Metab 2009;29(12):1933-1945.
57. Kuhlmann CR, Librizzi L, Closhen D, Pflanzner T, Lessmann V, Pietrzik CU, de Curtis M, Luhmann HJ. Mechanisms of C-reactive protein-induced blood-brain barrier disruption. Stroke 2009;40(4):1458-1466.
58. Luh C, Kuhlmann CR, Ackermann B, Timaru-Kast R, Luhmann HJ, Behl C, Werner C, Engelhard K, Thal SC. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury. J Neurochem 2010;112(4):1015-1025.
59. Cioffi DL, Barry C, Stevens T. Store-operated calcium entry channels in pulmonary endothelium: The emerging story of TRPCS and Orai1. Adv Exp Med Biol 2010;661:137-154.
60. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 2007;55(6):498-510.
61. Gaudreault N, Perrin RM, Guo M, Clanton CP, Wu MH, Yuan SY. Counter regulatory effects of PKCbetaII and PKCdelta on coronary endothelial permeability. Arterioscler Thromb Vasc Biol 2008;28(8):1527-1533.
62. Yuan SY, Ustinova EE, Wu MH, Tinsley JH, Xu W, Korompai FL, Taulman AC. Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circ Res 2000;87(5):412-417.
63. Wu HM, Yuan Y, Zawieja DC, Tinsley J, Granger HJ. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol 1999;276(2 Pt 2):H535-H542.
64. Willis CL, Meske DS, Davis TP. Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab 2010;30(11):1847-1859.
65. Fleegal MA, Hom S, Borg LK, Davis TP. Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol 2005;289(5):H2012-H2019.
66. Peng J, He F, Zhang C, Deng X, Yin F. Protein kinase C-alpha signals P115RhoGEF phosphorylation and RhoA activation in TNF-alpha-induced mouse brain microvascular endothelial cell barrier dysfunction. J Neuroinflamm 2011;8(1):28.
67. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997;46(9):1473-1480.
68. Aiello LP, Clermont A, Arora V, Davis MD, Sheetz MJ, Bursell SE. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients. Invest Ophthalmol Vis Sci 2006;47(1):86-92.
69. Kim JH, Jun HO, Yu YS, Kim KW. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy. Am J Pathol 2010;176(3):1517-1524.
70. Aveleira CA, Lin CM, Abcouwer SF, Ambrosio AF, Antonetti DA. TNF-alpha signals through PKCzeta/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 2010;59(11):2872-2882.
71. Oubaha M, Gratton JP. Phosphorylation of endothelial nitric oxide synthase by atypical PKC zeta contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro. Blood 2009;114(15):3343-3351.
72. Motley ED, Eguchi K, Patterson MM, Palmer PD, Suzuki H, Eguchi S. Mechanism of endothelial nitric oxide synthase phosphorylation and activation by thrombin. Hypertension 2007;49(3):577-583.
73. Duran WN, Breslin JW, Sanchez FA. The NO cascade, eNOS location, and microvascular permeability. Cardiovasc Res 2010;87(2):254-261.
74. Granger DN, Kubes P. Nitric oxide as anti-inflammatory agent. Methods Enzymol 1996;269:434-442.
75. Kemp-Harper B, Schmidt HH. cGMP in the vasculature. In: Schmidt HH, Hofmann F, Stasch J-P, editors. cGMP: Generators, Effectors and Therapeutic Implications. 2008/12/18 edition. Volume 191, Handb Exp Pharmacol. New York: Springer-Verlag; 2009. pp 447-468.
76. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 1993;264(5 Pt 2):H1734-H1739.
77. Yuan Y, Granger HJ, Zawieja DC, Chilian WM. Flow modulates coronary venular permeability by a nitric oxide-related mechanism. Am J Physiol 1992;263(2 Pt 2):H641-H646.
78. Wu HM, Huang Q, Yuan Y, Granger HJ. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 1996;271(6 Pt 2):H2735-H2739.
79. Huang Q, Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol 1997;273(5 Pt 2):H2442-H2451.
80. Hood J, Granger HJ. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 1998;273(36):23504-23508.
81. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, Ziche M. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J Biol Chem 1998;273(7):4220-4226.
82. Wu MH, Yuan SY, Granger HJ. The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules. J Physiol 2005;563(Pt 1):95-104.
83. Kasseckert SA, Schafer C, Kluger A, Gligorievski D, Tillmann J, Schluter KD, Noll T, Sauer H, Piper HM, Abdallah Y. Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation. Cardiovasc Res 2009;83(2):381-387.
84. Moldobaeva A, Welsh-Servinsky LE, Shimoda LA, Stephens RS, Verin AD, Tuder RM, Pearse DB. Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2006;290(5):L919-L930.
85. Chong TJ, Victorino GP. Cyclic nucleotide second messengers (cAMP and cGMP) play a central role in signal transduction and regulation of mesenteric postcapillary fluid leak. J Trauma 2005;59(2):302-306; discussion 306-307.
86. Patterson CE, Lum H, Schaphorst KL, Verin AD, Garcia JG. Regulation of endothelial barrier function by the cAMP-dependent protein kinase. Endothelium 2000;7(4):287-308.
87. Surapisitchat J, Jeon KI, Yan C, Beavo JA. Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3. Circ Res 2007;101(8):811-818.
88. Schmidt EP, Damarla M, Rentsendorj O, Servinsky LE, Zhu B, Moldobaeva A, Gonzalez A, Hassoun PM, Pearse DB. Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2008;295(6):L1056-L1065.
89. Werthmann RC, von Hayn K, Nikolaev VO, Lohse MJ, Bunemann M. Real-time monitoring of cAMP levels in living endothelial cells: Thrombin transiently inhibits adenylyl cyclase 6. J Physiol 2009;587(Pt 16):4091-4104.
90. Qian J, Zhang Q, Church JE, Stepp DW, Rudic RD, Fulton DJ. Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation. Am J Physiol Heart Circ Physiol 2010;298(1):H112-H118.
91. Boueiz A, Hassoun PM. Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc Res 2009;77(1):26-34.
92. Davidson SM, Duchen MR. Endothelial mitochondria: Contributing to vascular function and disease. Circ Res 2007;100(8):1128-1141.
93. Tran QK, Watanabe H. Calcium signalling in the endothelium. In: Moncada S, Higgs A, editors. The Vascular Endothelium I. 2006/09/27 edition. Volume 176, Handb Exp Pharmacol. New York: Springer-Verlag; 2006. 145-187.
94. Rodrigues SF, Granger DN. Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure. Cardiovasc Res 2010;87(2):291-299.
95. DiStasi MR, Ley K. Opening the flood-gates: How neutrophil-endothelial interactions regulate permeability. Trends Immunol 2009;30(11):547-556.
96. Carman CV, Springer TA. Trans-cellular migration: Cell-cell contacts get intimate. Curr Opin Cell Biol 2008;20(5):533-540.
97. He P. Leucocyte/endothelium interactions and microvessel permeability: Coupled or uncoupled? Cardiovasc Res 2010;87(2):281-290.
98. Carman CV. Mechanisms for transcellular diapedesis: Probing and pathfinding by 'invadosome-like protrusions'. J Cell Sci 2009;122(Pt 17):3025-3035.
99. Carman CV, Springer TA. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 2004;167(2):377-388.
100. Carman CV, Sage PT, Sciuto TE, de la Fuente MA, Geha RS, Ochs HD, Dvorak HF, Dvorak AM, Springer TA. Transcellular diapedesis is initiated by invasive podosomes. Immunity 2007;26(6):784-797.
101. Lewis RE, Granger HJ. Diapedesis and the permeability of venous microvessels to protein macromolecules: The impact of leukotriene B4 (LTB4). Microvasc Res 1988;35(1):27-47.
102. Kim MH, Curry FR, Simon SI. Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am J Physiol Cell Physiol 2009;296(4):C848-C856.
103. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, Auer M, Hub E, Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997;91(3):385-395.
104. Yuan SY, Wu MH, Ustinova EE, Guo M, Tinsley JH, De Lanerolle P, Xu W. Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circ Res 2002;90(11):1214-1221.
105. Tinsley JH, Zawieja DC, Wu MH, Ustinova EE, Xu W, Yuan SY. Protein transfection of intact microvessels specifically modulates vasoreactivity and permeability. J Vasc Res 2001;38(5):444-452.
106. Xu J, Gao XP, Ramchandran R, Zhao YY, Vogel SM, Malik AB. Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating beta2 integrins. Nat Immunol 2008;9(8):880-886.
107. Sun C, Wu MH, Yuan SY. Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration. Circulation 2011;124(1):48-57.
108. Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CR. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 2009;24(4):1023-1034.
109. Fischer S, Wiesnet M, Renz D, Schaper W. H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur J Cell Biol 2005;84(7):687-697.
110. Hecquet CM, Ahmmed GU, Vogel SM, Malik AB. Role of TRPM2 channel in mediating H2O2-induced Ca2+ entry and endothelial hyperpermeability. Circ Res 2008;102(3):347-355.
111. Hecquet CM, Ahmmed GU, Malik AB. TRPM2 channel regulates endothelial barrier function. Adv Exp Med Biol 2010;661:155-167.
112. Cai H, Davis ME, Drummond GR, Harrison DG. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 2001;21(10):1571-1576.
113. Cai H, Liu D, Garcia JG. CaM Kinase II-dependent pathophysiological signalling in endothelial cells. Cardiovasc Res 2008;77(1):30-34.
114. Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, de Vries HE. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 2007;21(13):3666-3676.
115. Arturson G. Forty years in burns research-the postburn inflammatory response. Burns 2000;26:599-604.
116. Cioffi WG. What's new in burns and metabolism. J Am Coll Surg 2001;192(2):241-254.
117. Gibran NS, Heimbach DM. Current status of burn wound pathophysiology. Clin Plast Surg 2000;27(1):11-22.
118. Lund T, Onarheim H, Reed RK. Pathogenesis of edema formation in burn injuries. World J Surg 1992;16(1):2-9.
119. Evers LH, Bhavsar D, Mailander P. The biology of burn injury. Exp Dermatol 2010;19(9):777-783.
120. Spanholtz TA, Theodorou P, Amini P, Spilker G. Severe burn injuries: Acute and long-term treatment. Dtsch Arztebl Int 2009;106(38):607-613.
121. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216(2):117-134.
122. Demling RH. The burn edema process: Current concepts. J Burn Care Rehabil 2005;26(3):207-227.
123. Breslin JW, Wu MH, Guo M, Reynoso R, Yuan SY. Toll-like receptor 4 contributes to microvascular inflammation and barrier dysfunction in thermal injury. Shock 2008;29(3):349-355.
124. Huxley VH, Curry FE, Adamson RH. Quantitative fluorescence microscopy on single capillaries: Alpha-lactalbumin transport. Am J Physiol 1987;252(1 Pt 2):H188-H197.
125. Witte S. Microphotometric techniques in intravital microcirculatory studies. J Microsc 1979;116(3):373-384.
126. Bekker AY, Ritter AB, Duran WN. Analysis of microvascular permeability to macromolecules by video-image digital processing. Microvasc Res 1989;38(2):200-216.
127. Huang Q, Xu W, Ustinova E, Wu M, Childs E, Hunter F, Yuan S. Myosin light chain kinase-dependent microvascular hyperpermeability in thermal injury. Shock 2003;20(4):363-368.
128. Finnerty CC, Przkora R, Herndon DN, Jeschke MG. Cytokine expression profile over time in burned mice. Cytokine 2009;45(1):20-25.
129. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanisms of endothelial hyperpermeability: Implications in inflammation. Expert Rev Mol Med 2009;11:e19.
130. Mileski WJ, Burkhart D, Hunt JL, Kagan RJ, Saffle JR, Herndon DN, Heimbach DM, Luterman A, Yurt RW, Goodwin CW, Hansborough J. Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. J Trauma 2003;54(5):950-958.
131. Piccolo MT, Wang Y, Verbrugge S, Warner RL, Sannomiya P, Piccolo NS, Piccolo MS, Hugli TE, Ward PA, Till GO. Role of chemotactic factors in neutrophil activation after thermal injury in rats. Inflammation 1999;23(4):371-385.
132. Shimizu S, Tanaka H, Sakaki S, Yukioka T, Matsuda H, Shimazaki S. Burn depth affects dermal interstitial fluid pressure, free radical production, and serum histamine levels in rats. J Trauma 2002;52(4):683-687.
133. Gibran NS, Heimbach DM. Mediators in thermal injury. Semin Nephrol 1993;13(4):344-358.
134. Kowal-Vern A, Walenga JM, Sharp-Pucci M, Hoppensteadt D, Gamelli RL. Postburn edema and related changes in interleukin-2, leukocytes, platelet activation, endothelin-1, and C1 esterase inhibitor. J Burn Care Rehabil 1997;18(2):99-103.
135. Kurose I, Wolf R, Miyasaka M, Anderson DC, Granger DN. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: Role of leukocytes. Am J Physiol 1996;270(2 Pt 1):G363-369.
136. Reynoso R, Perrin RM, Breslin JW, Daines DA, Watson KD, Watterson DM, Wu MH, Yuan S. A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns. Shock 2007;28(5):589-595.
137. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202(2):145-156.
138. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, Shriver MD, Ingersoll R, Scott AF, Beaty TH, Moitra J, Ma SF, Ye SQ, Barnes KC, Garcia JG. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006;34(4):487-495.
139. Christie JD, Ma SF, Aplenc R, Li M, Lanken PN, Shah CV, Fuchs B, Albelda SM, Flores C, Garcia JG. Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma. Crit Care Med 2008;36(10):2794-2800.
140. Wainwright MS, Rossi J, Schavocky J, Crawford S, Steinhorn D, Velentza AV, Zasadzki M, Shirinsky V, Jia Y, Haiech J, Van Eldik LJ, Watterson DM. Protein kinase involved in lung injury susceptibility: Evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci USA 2003;100(10):6233-6238.
141. Moitra J, Evenoski C, Sammani S, Wadgaonkar R, Turner JR, Ma SF, Garcia JG. A transgenic mouse with vascular endothelial over-expression of the non-muscle myosin light chain kinase-2 isoform is susceptible to inflammatory lung injury: Role of sexual dimorphism and age. Transl Res 2008;151(3):141-153.
142. Komarova YA, Mehta D, Malik AB. Dual regulation of endothelial junctional permeability. Sci STKE 2007;2007(412):re8.
143. Wang L, Dudek SM. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 2009;77(1):39-45.
144. Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, Palmer D, Pham TH, Wong JS, Pappu R, Coughlin SR. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 2009;119(7):1871-1879.
145. Sammani S, Moreno-Vinasco L, Mirzapoiazova T, Singleton PA, Chiang ET, Evenoski CL, Wang T, Mathew B, Husain A, Moitra J, Sun X, Nunez L, Jacobson JR, Dudek SM, Natarajan V, Garcia JG. Differential effects of S1P receptors on airway and vascular barrier function in the murine lung. Am J Respir Cell Mol Biol 2010; 43(4):394-402.
146. Zhao J, Singleton PA, Brown ME, Dudek SM, Garcia JG. Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: Role in barrier enhancement. Cell Signal 2009;21(12):1945-1960.
147. Dudek SM, Chiang ET, Camp SM, Guo Y, Zhao J, Brown ME, Singleton PA, Wang L, Desai A, Arce FT, Lal R, Van Eyk JE, Imam SZ, Garcia JG. Abl tyrosine kinase phosphorylates nonmuscle myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell 2010;21(22):4042-4056.
148. Dudek SM, Birukov KG, Zhan X, Garcia JG. Novel interaction of cortactin with endothelial cell myosin light chain kinase. Biochem Biophys Res Commun 2002;298(4):511-519.
149. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, Garcia JG. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: Roles for cortactin and myosin light chain kinase. J Biol Chem 2004;279(23):24692-24700.
150. Owens SE, Graham WV, Siccardi D, Turner JR, Mrsny RJ. A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase. Pharm Res 2005;22(5):703-709.
151. Rossi JL, Velentza AV, Steinhorn DM, Watterson DM, Wainwright MS. MLCK210 gene knockout or kinase inhibition preserves lung function following endotoxin-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2007;292(6):L1327-L1334.
152. Behanna HA, Watterson DM, Ranaivo HR. Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: A lead compound that attenuates vascular leak. Biochim Biophys Acta 2006;1763(11):1266-1274.
153. Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, Turner JR. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest 2005;115(10):2702-2715.
154. Ohlmann P, Tesse A, Loichot C, Ralay Ranaivo H, Roul G, Philippe C, Watterson DM, Haiech J, Andriantsitohaina R. Deletion of MLCK210 induces subtle changes in vascular reactivity but does not affect cardiac function. Am J Physiol Heart Circ Physiol 2005;289(6):H2342-2349.
155. van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 2002;39(4-5):257-272.
156. Paul R, Zhang ZG, Eliceiri BP, Jiang Q, Boccia AD, Zhang RL, Chopp M, Cheresh DA. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 2001;7(2):222-227.
157. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents. Pharmacol Ther 2006;109(3):366-398.